Eli Samaha Insider Profile
11 Followers
Eli Samaha, Ten Percent Owner at Theravance Biopharma, holds 9.17M shares in Theravance Biopharma (Ticker: TBPH), holds 8.19M shares in Stagwell (Ticker: STGW), holds 1.29M shares in Synovus (Ticker: SNV). Most recently, Eli Samaha Sold ― shares of Theravance Biopharma on Jul 08, 2026 for an estimated value of $119.39K.
Eli Samaha Theravance Biopharma (TBPH)Ten Percent Owner
Theravance Biopharma (TBPH)
Ten Percent Owner
Ranked #11,831 out of 108,437 Corporate Insiders
Profitable Transactions
13 out of 25 Profitable Transactions
Average Return
+9.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Eli Samaha holds in companies
Most Profitable Insider Trade
Stock:
Synovus
(SNV)
(SNV)
Rating:Informative Buy
Date:Oct 24, 2023 - Oct 24, 2024
Return:+51.90%
The most profitable trade made by Eli Samaha
Eli Samaha's Trading History
Theravance Biopharma
Jul 08, 2026
Ten Percent Owner
Informative Sell
119.39K
$154.56M
Stagwell
Jul 02, 2026
Director
Uninformative Buy
19.99K
$69.16M
PFSweb
Dec 30, 2022
―
Informative Buy
15.66M
$19.72M
Synovus
Jun 11, 2024
―
Informative Sell
4.36M
$64.73M
List of latest transactions for each holding click on a transaction to see Eli Samaha's performance on stock
You May Also Like
Eli Samaha insider profile FAQ
What is the percentage of profitable transactions made by Eli Samaha?
The percentage of profitable transactions made by Eli Samaha is 52%.
What is the average return per transaction made by Eli Samaha?
The average return per transaction made by Eli Samaha is 9.10%.
What stocks does Eli Samaha hold?
Eli Samaha holds: TBPH, STGW, PFSW, SNV stocks.
What was Eli Samaha’s latest transaction?
Eli Samaha latest transaction was an Informative Sell of $119.39K.
What was Eli Samaha's most profitable transaction?
Eli Samaha’s most profitable transaction was an Informative Buy of SNV stock on October 24, 2023. The return on the trade was 51.90%.
What is Eli Samaha's role in Theravance Biopharma?
Eli Samaha's role in Theravance Biopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.